Trial Profile
Phase III Trial Comparing Treatment With Melphalan+Prednisone (MP) With Melphalan+Prednisone+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2013
Price :
$35
*
At a glance
- Drugs Thalidomide (Primary) ; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 14 Aug 2013 Additional lead trial centre added as reported by ClinicalTrials.gov.
- 05 Dec 2009 Initial results from the Turkish Myeloma Study Group were presented at the 51st Annual Meeting and Exposition of the American Society of Hematology.
- 15 Jul 2009 New trial record